Provided by Tiger Trade Technology Pte. Ltd.

CorMedix Inc.

7.58
-0.1100-1.43%
Post-market: 7.670.0900+1.19%19:40 EST
Volume:1.34M
Turnover:10.19M
Market Cap:597.22M
PE:3.68
High:7.72
Open:7.66
Low:7.56
Close:7.69
52wk High:17.43
52wk Low:5.60
Shares:78.79M
Float Shares:73.69M
Volume Ratio:0.63
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.06
EPS(LYR):-0.3046
ROE:75.08%
ROA:15.68%
PB:1.60
PE(LYR):-24.89

Loading ...

CorMedix Authorizes Up to $75 Million Stock Buyback; Shares Rise

MT Newswires Live
·
Feb 02

CorMedix board authorizes share repurchase program of up to $75M

TIPRANKS
·
Feb 02

CorMedix Therapeutics Announces Share Repurchase Program

THOMSON REUTERS
·
Feb 02

CorMedix Hosts Analyst Day to Showcase Pipeline and Growth Drivers

Reuters
·
Jan 29

Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility?

Simply Wall St.
·
Jan 25

CorMedix Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 23

CorMedix Inc : H.c. Wainwright Cuts Target Price to $13 From $18

THOMSON REUTERS
·
Jan 23

CorMedix price target lowered to $13 from $18 at H.C. Wainwright

TIPRANKS
·
Jan 23

CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares

Reuters
·
Jan 23

CorMedix Inc : RBC Cuts Target Price to $13 From $22

THOMSON REUTERS
·
Jan 21

CorMedix Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Michael David Seckler

Reuters
·
Jan 16

CorMedix (CRMD) Valuation After New Leadership Moves And 2026 Revenue Guidance

Simply Wall St.
·
Jan 13

Analysts Conflicted on These Healthcare Names: Cormedix (CRMD), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Jan 13

Stock Track | CorMedix Inc. Plummets 5.24% Intraday After Leerink Partners Slashes Target Price

Stock Track
·
Jan 12

CorMedix Inc : Leerink Partners Cuts Target Price to $15 From $21

THOMSON REUTERS
·
Jan 12

Stock Track | CorMedix Inc. Soars 5.46% Intraday as CEO Prepares for J.P. Morgan Healthcare Conference Presentation

Stock Track
·
Jan 09

CorMedix CEO to Present Corporate Overview at J.P. Morgan Healthcare Conference

Reuters
·
Jan 09

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 09

Top Midday Decliners

MT Newswires Live
·
Jan 09

CorMedix price target lowered to $16 from $20 at Truist

TIPRANKS
·
Jan 09